Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants

Recruiting Phase 1 Interventional Study
Healthy
Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
25 and older
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Basic Science
Participants needed
24 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The primary objective of this study is to determine whether equivalent moderately high doses of LSD, psilocybin, and DMT produce qualitatively similar peak effects when the effect duration is standardized with ketanserin. A DMT infusion mimicking oral LSD and psilocybin administrations will be tested, as well as intravenously administered ketanserin.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Good understanding of the German language 2. Understanding of procedures and risks associated with the study 3. Willing to adhere to the protocol and signing of the consent form 4. Willing to refrain from the consumption of illicit psychoactive substances during the study 5. …
Contacts

Matthias E Liechti, Prof. Dr. MD

61 328 68 68

matthias.liechti@usb.ch

CONTACT

Mélusine Humbert-Droz, MSc

61 328 48 19

melusine.humbert-droz@usb.ch

CONTACT